Tag: FDA Approvalsindex/list_13471_7

FDA Clears Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy

FDA Approves Medtronic’s Next-Gen Evolut FX TAVR System

FDA Okays New PAD Indication for Rivaroxaban (Xarelto)

FDA Okays Empagliflozin for HFrEF